Understanding resistance mechanisms and expanding the therapeutic utility of PARP inhibitors

by Lim, J.S.J, Tan, D.S.P
Published 2020

Maintaining breast cancer care in the face of COVID-19

by Ng, CWQ, Tseng, M, Lim, JSJ, Chan, CW
Published 2020

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

by Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C.
Published 2021

Oncofetal gene SALL4 in aggressive hepatocellular carcinoma

by Yong, K.J., Gao, C., Lim, J.S.J., Yan, B., Yang, H., Dimitrov, T., Kawasaki, A., Ong, C.W., Wong, K.-F., Lee, S., Ravikumar, S., Srivastava, S., Tian, X., Poon, R.T., Fan, S.T., Luk, J.M., Dan, Y.Y., Salto-Tellez, M., Chai, L., Tenen, D.G.
Published 2014

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

by Lim, JSJ, Wong, ALA, Ow, SGW, Ngoi, NYL, Chan, GHJ, Ang, YLE, Chong, WQ, Lim, SE, Lim, YW, Lee, M, Choo, JRE, Tan, HL, Yong, WP, Soo, RA, Tan, DSP, Chee, CE, Sundar, R, Yadav, K, Jain, S, Wang, L, Tai, BC, Goh, BC, Lee, SC
Published 2023

Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: A pilot study

by Sundar, R, Bandla, A, Tan, S.S.H, Liao, L.-D, Kumarakulasinghe, N.B, Jeyasekharan, A.D, Ow, S.G.W, Ho, J, Tan, D.S.P, Lim, J.S.J, Vijayan, J, Therimadasamy, A.K, Hairom, Z, Ang, E, Ang, S, Thakor, N.V, Lee, S.-C, Wilder-Smith, E.P.V
Published 2020

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib

by Wong A.L.A., Lim J.S.J., Sinha A., Gopinathan A., Lim R., Tan C.-S., Soh T., Venkatesh S., Titin C., Sapari N.S., Lee S.-C., Yong W.-P., Tan D.S.P., Pang B., Wang T.-T., Zee Y.-K., Soong R., Trnkova Z., Lathia C., Thiery J.-P., Wilhelm S., Jeffers M., Goh B.-C.
Published 2018

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients

by Lim, L.Y., Miao, H., Lim, J.S.J., Lee, S.C., Bhoo-Pathy, N., Yip, C.H., Mohd Taib, N.A., Chan, P., Tan, E.Y., Lim, S.H., Lim, G.H., Woo, E., Tan, Y.S., Lee, J.A., Wong, M., Tan, P.H., Ong, K.W., Wong, F.Y., Yap, Y.S., Hartman, M.
Published 2016

Low Levels of NDRG1 in nerve tissue are predictive of severe paclitaxel-induced neuropathy

by Sundar R., Jeyasekharan A.D., Pang B., Soong R.C.T., Kumarakulasinghe N.B., Ow S.G.W., Ho J., Lim J.S.J., Tan D.S.P., Wilder-Smith E.P.V., Bandla A., Tan S.S.H., Asuncion B.R., Fazreen Z., Hoppe M.M., Putti T.C., Poh L.M., Goh B.C., Lee S.-C.
Published 2018

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients

by Lim L.Y., Miao H., Lim J.S.J., Lee S.C., Bhoo-Pathy N., Yip C.H., Taib N.A.B.M., Chan P., Tan E.Y., Lim S.H., Lim G.H., Woo E., Tan Y.S., Lee J.A., Wong M., Tan P.H., Ong K.W., Wong F.Y., Yap Y.S., Hartman M.
Published 2018